Authors:
SAYAD DE
WILLETT DL
HUNDLEY WG
GRAYBURN PA
PESHOCK RM
Citation: De. Sayad et al., DOBUTAMINE MAGNETIC-RESONANCE-IMAGING WITH MYOCARDIAL TAGGING QUANTITATIVELY PREDICTS IMPROVEMENT IN REGIONAL FUNCTION AFTER REVASCULARIZATION, The American journal of cardiology, 82(9), 1998, pp. 1149
Authors:
TANAKA H
DINENNO FA
HUNT BE
JONES PP
DESOUZA CA
SEALS DR
Citation: H. Tanaka et al., HEMODYNAMIC SEQUELAE OF AGE-RELATED INCREASES IN ARTERIAL STIFFNESS IN HEALTHY WOMEN, The American journal of cardiology, 82(9), 1998, pp. 1152
Citation: Aa. Steinberg et al., EFFECT OF END-STAGE RENAL-DISEASE ON DECREASED HEART-RATE-VARIABILITY, The American journal of cardiology, 82(9), 1998, pp. 1156
Authors:
KOMATSU S
SAKATA Y
UEDA Y
HIGUCHI Y
ISHIKURA F
HIRAYAMA A
MISHIMA M
KUSUOKA H
HASEGAWA M
KODAMA K
Citation: S. Komatsu et al., ESTIMATION OF SHUNT FLOW IN CORONARY-PULMONARY FISTULA BY LUNG PERFUSION SCINTIGRAPHY WITH TC-99M MACROAGGREGATED ALBUMIN, The American journal of cardiology, 82(9), 1998, pp. 1158
Citation: Ej. Topol et Hd. White, A SYMPOSIUM - ANTICOAGULANT-THERAPY - NEW PROMISES AND CHALLENGES - INTRODUCTION, The American journal of cardiology, 82, 1998, pp. 1-2
Citation: Sm. Bates et Ji. Weitz, DIRECT THROMBIN INHIBITORS FOR TREATMENT OF ARTERIAL THROMBOSIS - POTENTIAL DIFFERENCES BETWEEN BIVALIRUDIN AND HIRUDIN, The American journal of cardiology, 82, 1998, pp. 12-18
Citation: Rm. Califf, A PERSPECTIVE ON THE REGULATION OF THE EVALUATION OF NEW ANTITHROMBOTIC DRUGS, The American journal of cardiology, 82, 1998, pp. 25-35
Citation: Am. Lincoff, TRIALS OF PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONISTS DURING PERCUTANEOUS CORONARY REVASCULARIZATION/, The American journal of cardiology, 82, 1998, pp. 36-42
Citation: Ja. Bittl et F. Feit, A RANDOMIZED COMPARISON OF BIVALIRUDIN AND HEPARIN IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY FOR POSTINFARCTION ANGINA, The American journal of cardiology, 82, 1998, pp. 43-49
Citation: Ja. Bittl et Wh. Ahmed, RELATION BETWEEN ABRUPT VESSEL CLOSURE AND THE ANTICOAGULANT RESPONSETO HEPARIN OR BIVALIRUDIN DURING CORONARY ANGIOPLASTY, The American journal of cardiology, 82, 1998, pp. 50-56
Citation: Hd. White, DIRECT THROMBIN INHIBITION AND THROMBOLYTIC THERAPY - RATIONALE FOR THE HIRULOG AND EARLY REPERFUSION OCCLUSION (HERO-2) TRIAL/, The American journal of cardiology, 82, 1998, pp. 57-62
Citation: Ej. Topol, EVOLUTION OF IMPROVED ANTITHROMBOTIC AND ANTIPLATELET AGENTS - GENESIS OF THE COMPARISON OF ABCIXIMAB COMPLICATIONS WITH HIRULOG [AND BACKUP ABCIXIMAB] EVENTS TRIAL (CACHET), The American journal of cardiology, 82, 1998, pp. 63-68
Citation: Ja. Reiffel et J. Camm, A SYMPOSIUM - ATRIAL-FIBRILLATION - MECHANISM AND MANAGEMENT - INTRODUCTION, The American journal of cardiology, 82, 1998, pp. 1-1
Citation: Wb. Kannel et al., PREVALENCE, INCIDENCE, PROGNOSIS, AND PREDISPOSING CONDITIONS FOR ATRIAL-FIBRILLATION - POPULATION-BASED ESTIMATES, The American journal of cardiology, 82, 1998, pp. 2-8
Citation: Rh. Falk, ETIOLOGY AND COMPLICATIONS OF ATRIAL-FIBRILLATION - INSIGHTS FROM PATHOLOGY STUDIES, The American journal of cardiology, 82, 1998, pp. 10-16
Authors:
SUNG R
FALK RH
CAMM J
REIFFEL JA
KERR CR
WALDO A
WHARTON M
KAUFMAN E
Citation: R. Sung et al., ATRIAL-FIBRILLATION - ETIOLOGY, HISTOLOGY AND RISK-FACTORS - DISCUSSION, The American journal of cardiology, 82, 1998, pp. 16-17
Citation: B. Schumacher et B. Luderitz, RATE ISSUES IN ATRIAL-FIBRILLATION CONSEQUENCES OF TACHYCARDIA AND THERAPY FOR RATE CONTROL, The American journal of cardiology, 82, 1998, pp. 29-35
Citation: K. Nademanee et Em. Kosar, LONG-TERM ANTITHROMBOTIC TREATMENT FOR ATRIAL-FIBRILLATION, The American journal of cardiology, 82, 1998, pp. 37-41